Active Site Mutations in DNA Topoisomerase I Distinguish the Cytotoxic Activities of Camptothecin and the Indolocarbazole, Rebeccamycin
Open Access
- 1 February 2002
- journal article
- Published by Elsevier
- Vol. 277 (6) , 3813-3822
- https://doi.org/10.1074/jbc.m110484200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Mechanisms of DNA Topoisomerase I‐Induced Cell Killing in the Yeast: Saccharomyces cerevisiaeAnnals of the New York Academy of Sciences, 2000
- Role for Nucleolin/Nsr1 in the Cellular Localization of Topoisomerase IPublished by Elsevier ,2000
- Substitutions of Asn-726 in the Active Site of Yeast DNA Topoisomerase I Define Novel Mechanisms of Stabilizing the Covalent Enzyme-DNA IntermediateJournal of Biological Chemistry, 2000
- Synthesis and biological activities of NB-506 analogues: Effects of the positions of two hydroxyl groups at the indole ringsBioorganic & Medicinal Chemistry Letters, 1999
- The Camptothecin-Resistant Topoisomerase I Mutant F361S Is Cross-Resistant to Antitumor Rebeccamycin Derivatives. A Model for Topoisomerase I Inhibition by IndolocarbazolesBiochemistry, 1999
- Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase IPublished by Elsevier ,1998
- A Model for the Mechanism of Human Topoisomerase IScience, 1998
- Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell DeathPublished by Elsevier ,1997
- DNA Cleavage by Topoisomerase I in the Presence of Indolocarbazole Derivatives of RebeccamycinBiochemistry, 1997
- A Camptothecin-resistant DNA Topoisomerase I Mutant Exhibits Altered Sensitivities to Other DNA Topoisomerase PoisonsPublished by Elsevier ,1995